EOS imaging: 2015 Financial Calendar

Regulatory News:

EOS Imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, announced its financial reporting schedule for 2015 today.

Financial publications will be released after market close. This schedule is indicative and subject to change.

• 2014 Full-year sales: Wednesday January 21, 2015
• 2014 Full-year results: Monday April 20, 2015
• 2015 First-quarter sales: Monday April 20, 2015
• 2015 First-half sales: Monday July 20, 2015
• 2015 First-half results: Tuesday September 1, 2015
• 2015 Third-quarter sales: Monday October 19, 2015

For further information about the Company or EOS®, the first full-body, low dose 2D/3D imaging system, please visit www.eos-imaging.com.

EOS imaging has been chosen to be included in the new EnterNext^© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

About EOS imaging:
EOS imaging designs, develops, and markets EOS® and associated solutions, an innovative medical imaging system based on technology that enabled George Charpak to win the Nobel Prize for Physics. The Company is authorized to market in 34 countries, including the United States (FDA), Japan and the European Union (EU). As of December 31, 2013 the Group posted 2013 consolidated revenue of €15.2 million and employed 106 people including an R&D team of 38 engineers. The Group is based in Paris and holds four subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada) and Frankfurt (Germany), and offices in Singapore.

EOS imaging is listed on Compartment C of the Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI
Next press release: 2014 Full-year sales on January 21, 2015 (after market)